SIGN UP
LOG IN
Why Cheetah Mobile Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
Benzinga·06/20/2025 10:01:09
Listen to the news
Shares of Cheetah Mobile Inc. (NYSE:CMCM) rose sharply in pre-market trading following first-quarter results.
Cheetah Mobile posted a quarterly loss of 11 cents per share, versus a year-ago loss of 32 cents per share. The company's quarterly sales rose to $35.69 million from $26.35 million in the year-ago period.
Cheetah Mobile shares surged 11.2% to $4.57 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
- Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) surged 129.6% to $7.85 in pre-market trading. On May 21, Wheeler Real Estate Investment Trust announced it will implement a 1-for-7 reverse stock split.
- Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) shares jumped 108% to $0.4534 in pre-market trading after gaining 6% on Wednesday.
- Baiya International Group Inc. (NASDAQ:BIYA) gained 36.2% to $1.13 in pre-market trading.
- Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) jumped 32.2% to $0.32 in pre-market trading. On Tuesday, Processa Pharmaceuticals announced the pricing of $7 million public offering.
- GMS Inc. (NYSE:GMS) rose 21.2% to $98.22 in pre-market trading. GMS confirmed the receipt of $95.20 per share unsolicited buyout proposal from QXO.
- Beasley Broadcast Group, Inc. (NASDAQ:BBGI) rose 19.5% to $5.57 in pre-market trading after gaining 5% on Wednesday.
- Arqit Quantum Inc. (NASDAQ:ARQQ) gained 15.2% to $43.74 in pre-market trading after surging over 22% on Wednesday.
- Oscar Health, Inc. (NYSE:OSCR) fell 13.3% to $21.31 in pre-market trading after gaining more than 16% on Wednesday.
- GeoVax Labs, Inc. (NASDAQ:GOVX) climbed 10.4% to $1.02 in pre-market trading. GeoVax Labs recently in a filing disclosed it will sell 6.15 million common units.
Losers
- Nature Wood Group Limited (NASDAQ:NWGL) shares tumbled 52.8% to $2.66 in pre-market trading after surging over 142% on Wednesday.
- Regencell Bioscience Holdings Ltd (NASDAQ:RGC) shares fell 16.2% to $52.96 in pre-market trading after dipping over 18% on Wednesday.
- PTL Ltd (NASDAQ:PTLE) dipped 16.2% to $0.30 in pre-market trading after surging 84% on Wednesday.
- Cambium Networks Corp (NASDAQ:CMBM) declined 12.9% to $0.36 in pre-market trading after gaining over 16% on Wednesday. Cambium Networks, last month, announced it received a Nasdaq noncompliance notice.
- Smith & Wesson Brands Inc (NASDAQ:SWBI) declined 12.6% to $9.51 in pre-market trading after the company reported worse-than-expected fourth-quarter EPS and sales.
- Cellectar Biosciences Inc (NASDAQ:CLRB) dipped 12.4% to $0.32 in pre-market trading. Cellectar Biosciences announced a 1-for-30 reverse stock split, effective June 24.
- QuantaSing Group Ltd- ADR (NASDAQ:QSG) fell 12.1% to $11.86 in pre-market trading.
- Aptevo Therapeutics Inc (NASDAQ:APVO) fell 11.9% to $4.52 in pre-market trading. Aptevo Therapeutics shares jumped 82% on Wednesday after the company announced clinical data from its ongoing Phase 1b/2 RAINIER trial evaluating mipletamig.
- Capricor Therapeutics Inc (NASDAQ:CAPR) fell 7.4% to $11.04 in pre-market trading. Capricor Therapeutics recently announced Orphan Drug designation for Becker Muscular Dystrophy.
- Mesoblast Ltd (NASDAQ:MESO) fell 6.5% to $10.94 in pre-market trading.
Now Read This:
Photo via Shutterstock
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.